Results 121 to 130 of about 3,174,183 (342)
On the Biochemical Mechanism of Growth. The Effect of Sodium and Calcium Ions on the Growth of a Transplantable Mouse Carcinoma [PDF]
, 1918 William A. Cramer
openalex +1 more source
Carcinoma of the Ureter and Carcinoma of Bronchus [PDF]
Proceedings of the Royal Society of Medicine, 1959 R. J. Ryall, Eric Riches
openaire +3 more sources
Clinical & Biomedical Research, 2016 Thymic carcinomas are a heterogeneous group of aggressive, invasive epithelial malignancies. Their incidence is rare, occurring predominantly in middle-aged men. Here we present the typical imaging findings of a thymic carcinoma. The combination of imaging characteristics with tumor location and patient age provides a roadmap for approaching the ...
Machado, Vitória Homem +2 more
openaire +5 more sources
Molecular Oncology, EarlyView.This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau +9 more
wiley +1 more source
Scientific ReportsTo assess the efficacy and safety of the combination of immune checkpoint inhibitors (ICIs) and target therapy (anti-angiogenesis or EGFR inhibitors) as a second-line or subsequent treatment for recurrent or metastatic nasopharyngeal carcinoma (R/M NPC),
Yaofei Jiang +10 more
doaj +1 more source
THE RADICAL ABDOMINAL OPERATION FOR CARCINOMA OF THE CERVIX UTERI: Result of One Hundred Cases Reckoned on an Absolute Cure Basis [PDF]
, 1916 Comyns Berkeley, Victor Bonney
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source
Carcinoma of the Pancreas in Say's Pine Snake, Pituophis Sayi [PDF]
, 1935 Herbert L. Ratcliffe
openalex +1 more source
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source